Leserbrief
Invisible No More: How Redefining Rare Diseases Can Advance Health Equity
The Journal of Clinical Pharmacology · 2026-03 · 66 (3)
DOI: 10.1002/jcph.70179 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Clinical Pharmacology, online erschienen am 19.03.2026. Verfasst von Rajesh Krishna. Beteiligte Einrichtung: Certara USA, Inc., Radnor, PA, USA. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Certara USA, Inc., Radnor, PA, USA.
ORCID-Profile: Rajesh Krishna
Zitieren
APA
Krishna, R. (2026). Invisible No More: How Redefining Rare Diseases Can Advance Health Equity. The Journal of Clinical Pharmacology, 66(3). https://doi.org/10.1002/jcph.70179
Vancouver
Krishna R. Invisible No More: How Redefining Rare Diseases Can Advance Health Equity. The Journal of Clinical Pharmacology. 2026;66(3). doi:10.1002/jcph.70179
BibTeX
@article{Krishna2026,
author = {Krishna, Rajesh},
title = {Invisible No More: How Redefining Rare Diseases Can Advance Health Equity},
journal = {The Journal of Clinical Pharmacology},
year = {2026},
volume = {66},
number = {3},
doi = {10.1002/jcph.70179}
}
EUVIMED